Skip to main content
Log in

Analytical validation of the GeXP analyzer and design of a workflow for cancer-biomarker discovery using multiplexed gene-expression profiling

  • Original Paper
  • Published:
Analytical and Bioanalytical Chemistry Aims and scope Submit manuscript

Abstract

The GeXP genetic analysis system allows for multiplexed detection and quantitation of up to 35 genes in 192 samples in a single analysis. The analytical procedure includes modified reverse transcription and PCR amplification, followed by capillary electrophoretic separation. RNA material from multiple sample types can be used, including blood, cell lines, and tissue material. This instrumentation has a lower limit of detection of <2 ng with a dynamic range greater than two orders of magnitude, as tested in this validation. Precision experiments demonstrate a within-run coefficient-of-variation (CV) = 11.1% at 25 ng and 12.9% at 12.5 ng total RNA for the complete workflow and CV = 4.8% at 25 ng and 6.7% at 12.5 ng levels for the GeXP analysis alone. The between-run precision for the entire workflow was determined to be 25% at 25 ng. We have devised an optimized protocol and use it to successfully identify a gene expression signature capable of discriminating prostate tumor and non-tumor tissue samples. We used a combination of multiplex gene panels to interrogate ~70 genes in our primary screen. Our results demonstrate that a subset of these genes can be used to separate normal and tumor prostate tissue samples. This protocol using the GeXP analyzer allows for a high-throughput, robust, and reproducible assessment of multiplexed gene expression analysis, and can be used for biomarker discovery to compare different sample groups. With a dynamic linear range and satisfactory precision, this technology holds promise for rapidly identifying gene expression signatures from multiplexed reactions of up to 35 genes in large numbers of samples with limited amounts of starting material.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

References

  1. Brennan DJ, Kelly C, Rexhepaj E, Dervan PA, Duffy MJ, Gallagher WM (2007) Cancer Genomics Proteomics 4:121–134

    CAS  Google Scholar 

  2. Editorial (2006) Nat Biotech 24:1039

  3. Page GP, Zakharkin SO, Kim K, Mehta T, Chen L, Zhang K (2007) Methods Mol Biol 404:409–430

    Article  CAS  Google Scholar 

  4. Smith GW, Rosa GJ (2007) J Anim Sci 85:E20–E23

    Article  CAS  Google Scholar 

  5. Liang P (2007) Nat Biotech 25:27–28

    Article  CAS  Google Scholar 

  6. http://www.beckman.com/products/instrument/geneticanalysis/gexp_inst_dcr.asp

  7. Singh D, Febbo PG, Ross K, Jackson DG, Manola J, Ladd C, Tamayo P, Renshaw AA, D’Amico AV, Richie JP, Lander ES, Loda M, Kantoff PW, Golub TR, Sellers WR (2002) Cancer Cell 1:203–209

    Article  CAS  Google Scholar 

  8. International Conference on Harmonization, http://www.ich.org/cache/compo/276-254-1.html

  9. Seth D, Shaw K, Jazayeri J, Leedman PJ (1999) Br J Cancer 80:657–669

    Article  CAS  Google Scholar 

  10. Hanahan D, Weinberg RA (2000) Cell 100:57–70

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Alex J. Rai.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rai, A.J., Kamath, R.M., Gerald, W. et al. Analytical validation of the GeXP analyzer and design of a workflow for cancer-biomarker discovery using multiplexed gene-expression profiling. Anal Bioanal Chem 393, 1505–1511 (2009). https://doi.org/10.1007/s00216-008-2436-7

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00216-008-2436-7

Keywords

Navigation